Compare MRNA & AWI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MRNA | AWI |
|---|---|---|
| Founded | 2010 | 1860 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Plastic Products |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3B | 8.6B |
| IPO Year | 2018 | 2006 |
| Metric | MRNA | AWI |
|---|---|---|
| Price | $25.14 | $187.65 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 13 | 7 |
| Target Price | $33.91 | ★ $203.14 |
| AVG Volume (30 Days) | ★ 10.0M | 301.6K |
| Earning Date | 11-06-2025 | 10-28-2025 |
| Dividend Yield | N/A | ★ 0.72% |
| EPS Growth | N/A | ★ 23.00 |
| EPS | N/A | ★ 6.97 |
| Revenue | ★ $2,232,000,000.00 | $1,600,200,000.00 |
| Revenue This Year | N/A | $14.06 |
| Revenue Next Year | $0.77 | $6.91 |
| P/E Ratio | ★ N/A | $26.96 |
| Revenue Growth | N/A | ★ 15.10 |
| 52 Week Low | $22.28 | $122.37 |
| 52 Week High | $48.92 | $206.08 |
| Indicator | MRNA | AWI |
|---|---|---|
| Relative Strength Index (RSI) | 50.59 | 47.52 |
| Support Level | $23.92 | $187.34 |
| Resistance Level | $26.00 | $193.66 |
| Average True Range (ATR) | 1.19 | 4.10 |
| MACD | 0.09 | 0.92 |
| Stochastic Oscillator | 72.59 | 61.72 |
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Armstrong World Industries Inc. designs, innovates, and manufactures ceiling and wall solutions in the Americas. The company manufactures and sources products made of numerous materials, including mineral fiber, fiberglass, metal, felt, wood, resin, wood fiber, and glass-reinforced-gypsum. It also manufactures ceiling suspension system (grid) products through a joint venture with Worthington Industries, Inc., called Worthington Armstrong Venture (WAVE). The company's reportable operating segments include Mineral Fiber, Architectural Specialties, and Unallocated Corporate. A majority of its revenue is generated from the Mineral Fiber segment, which produces suspended mineral fiber and fiberglass ceiling systems. Geographically, it derives maximum revenue from the United States.